BCR and B-cell chronic lymphocytic leukemia: We had initiated our study based on the hypothesis that strong activation of the PI3K/AKT pathway mimics excessive signaling strength from an autoreactive BCR and that this may be leveraged to trigger negative selection for therapeutic benefit in CLL patients.